Dawnrays pharmaceutical holdings limited
WebDawnrays Pharmaceutical Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. The company operates in two segments, Intermediates and Bulk … WebDawnrays Pharmaceutical CFD - Hong Kong Stock Exchange (CFD): 2348 CFD търговия, Акция цени на живо онлайн. Купувай и продавай 2348 CFD-та с висок маржин: търгувай дългосрочно или краткосрочно с ливъридж с Trading 212.
Dawnrays pharmaceutical holdings limited
Did you know?
WebDawnrays Pharmaceutical (Holdings) Ltd is a major drug manufacturing company. The company operates two segments, including Intermediates and Bulk Medicines, and Finished Drugs. Most of its revenue is derived from the Finished Drugs segment. Nearly all of the company's sales are generated in Mainland China. It utilizes strategic partnerships as ... http://en.dawnrays.com/About/Dawnrays05.aspx
WebAfter several years of efforts, Dawnrays Pharma finally became the first one that grasped the international competitive production technology of cefoperazone solvent crystallization in China around 2000. Before long, the cephalosporin antibiotic products produced by Dawnrays Pharma had been the favourite in Chinese pharmaceutical market. WebSep 19, 2024 · Dawnrays Pharmaceutical (Holdings)'s next dividend payment will be HK$0.01 per share, on the back of last year when the company paid a total of HK$0.07 to shareholders.
WebDec 9, 2024 · Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. See The Free Research Report. The Snowflake is a visual investment summary with the score of each axis being calculated by 6 checks in 5 …
WebDec 31, 2024 · Dawnrays Pharmaceutical (Holdings) Limited proposed Final Dividend for the Year Ended 31 December 2024 HKD 0.073 per share, Date of shareholders' approval is 25 May 2024. Ex-dividend date is 30 May 2024. Record date is 02 June 2024. Payment date is 13 June 2024.
WebJan 30, 2024 · Dawnrays Pharmaceutical (Holdings) Limited ( SEHK:2348 ), a pharmaceuticals company based in Hong Kong, received a lot of attention from a substantial price movement on the SEHK in the over the... knk electrical wholesalersWeb3 rows · Dec 31, 2024 · Dawnrays Pharmaceutical (Holdings) Limited is an investment holding company principally engaged in ... knk golf cartsWeb“Company”: Dawnrays Pharmaceutical (Holdings) Limited, a company incorporated in the Cayman Islands with limited liability and the shares of which are listed on the main board of the Stock Exchange (stock code: 2348.HK); “Completion” the completion of the Disposal pursuant to the terms and conditions of the Sale and Purchase Agreement; knk hardware rchttp://en.dawnrays.com/Investor/Overview.aspx red dragon s113 softwareWebDAWNRAYS PHARMACEUTICAL (HOLDINGS) LIMITED Company Profile Wan Chai, Hong Kong Competitors, Financials & Contacts - Dun & Bradstreet. Find company research, competitor information, contact details & financial data for DAWNRAYS … red dragon s113WebDawnrays Pharmaceutical (Holdings) Limited Announces Interim Semi-Annual Ordinary Dividend for the Six Months Ended 30 June 2024, Payable on 05 October 2024 Aug 27. Dawnrays Pharmaceutical (Holdings) Limited to Report First Half, 2024 Results on Aug 26, 2024 Aug 16. red dragon s101 ba 2WebComplete Dawnrays Pharmaceutical (Holdings) Ltd. stock information by Barron's. View real-time 2348 stock price and news, along with industry-best analysis. red dragon s101-3